APA (7th ed.) Citation

Sílvia Castany, Xavier Codony, Daniel Zamanillo, Manuel Merlos, Enrique Verdú, & Pere Boadas-Vaello. (2019). Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Sílvia Castany, Xavier Codony, Daniel Zamanillo, Manuel Merlos, Enrique Verdú, and Pere Boadas-Vaello. Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice. Frontiers Media S.A., 2019.

MLA (9th ed.) Citation

Sílvia Castany, et al. Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice. Frontiers Media S.A., 2019.